You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

NORFLEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Norflex patents expire, and when can generic versions of Norflex launch?

Norflex is a drug marketed by Pai Holdings Pharm and Bausch and is included in two NDAs.

The generic ingredient in NORFLEX is orphenadrine citrate. There are nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the orphenadrine citrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Norflex

A generic version of NORFLEX was approved as orphenadrine citrate by WATSON LABS on March 15th, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NORFLEX?
  • What are the global sales for NORFLEX?
  • What is Average Wholesale Price for NORFLEX?
Summary for NORFLEX
Drug patent expirations by year for NORFLEX
Recent Clinical Trials for NORFLEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
OSF Healthcare SystemPhase 4
University of Illinois College of Medicine at PeoriaPhase 4
AdventHealthPhase 4

See all NORFLEX clinical trials

US Patents and Regulatory Information for NORFLEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pai Holdings Pharm NORFLEX orphenadrine citrate INJECTABLE;INJECTION 013055-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch NORFLEX orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 012157-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.